Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,230 | -11,431 | -10,184 | -7,869 | -4,073 |
| Depreciation Amortization | 1,245 | 4,812 | 3,606 | 2,397 | 1,187 |
| Accounts receivable | 4,761 | -19,341 | -7,582 | -5,167 | -7,989 |
| Accounts payable and accrued liabilities | -632 | -7,272 | -4,266 | -2,984 | -1,775 |
| Other Working Capital | 2,875 | -11,899 | -3,922 | -715 | -1,464 |
| Other Operating Activity | -3,110 | 32,690 | 16,191 | 10,564 | 11,282 |
| Operating Cash Flow | $2,909 | $-12,441 | $-6,157 | $-3,774 | $-2,832 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -625 | -625 | -625 | -625 |
| Common Stock Issued | 220 | 16,926 | 11,500 | 4,387 | 4,222 |
| Other Financing Activity | 0 | -75 | -75 | 0 | 0 |
| Financing Cash Flow | $220 | $16,226 | $10,800 | $3,762 | $3,597 |
| Beginning Cash Position | 24,090 | 20,305 | 20,305 | 20,305 | 20,305 |
| End Cash Position | 27,219 | 24,090 | 24,948 | 20,293 | 21,070 |
| Net Cash Flow | $3,129 | $3,785 | $4,643 | $-12 | $765 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,909 | -12,441 | -6,157 | -3,774 | -2,832 |
| Free Cash Flow | 2,909 | -12,441 | -6,157 | -3,774 | -2,832 |